clarithromycin has been researched along with Tuberculosis, Multidrug-Resistant in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 12 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkerman, OW; Aleksa, A; Alffenaar, JC; Bolhuis, MS; Davies Forsman, L; de Lange, WC; Gualano, G; Kosterink, JG; Migliori, GB; Palmieri, F; Skrahina, A; Tiberi, S; Van der Paardt, AL; van der Werf, TS; van Soolingen, D | 1 |
| Jo, KW; Nam, GB; Shim, TS; Yoon, HY | 1 |
| Alffenaar, JW; Bolhuis, MS; de Lange, WC; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS; van Soolingen, D | 1 |
| Alffenaar, JW; Bolhuis, MS; de Lange, WC; Greijdanus, B; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS; van Hateren, K | 1 |
| Alcántara, F; Atwood, SS; Becerra, MC; Bonilla, CA; Mitnick, CD; Seung, KJ | 1 |
| Migliori, GB; Peloquin, CA; Sotgiu, G; Srivastava, S | 1 |
| Alffenaar, JW; Bolhuis, MS; Kosterink, JG; van der Laan, T; van der Werf, TS; van Soolingen, D | 1 |
| Butler-Laporte, G; Menzies, D; Winters, N | 1 |
| Betsuyaku, T; Goto, H; Hasegawa, N; Hayashi, Y; Hoshino, Y; Ishii, M; Izumi, K; Kurashima, A; Matsuda, S; Morimoto, K; Morino, E; Nakagawa, T; Namkoong, H; Nishimura, T; Ogawa, K; Sasaki, Y; Shiraishi, Y; Takasaki, J; Yoshiyama, T | 1 |
| Fu, L; Li, P; Liang, BW; Lu, Y; Wang, B; Zhao, WJ; Zheng, MQ | 1 |
| Andries, K; Bantubani, N; De Marez, T; Diacon, AH; Donald, PR; Grobusch, M; Lounis, N; Mahanyele, R; McNeeley, DF; Meyvisch, P; Narasimooloo, R; Patientia, RF; Pym, A; van Heeswijk, R | 1 |
| Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
| Dediste, A; Portaels, F; Rigouts, L; Shamputa, IC; Struelens, M; Umubyeyi, A | 1 |
| Biehle, JR; Cavalieri, SJ; Sanders, WE | 1 |
| Coker, RJ; Fisher, M; Tomlinson, DR | 1 |
| Griffith, DE | 1 |
2 review(s) available for clarithromycin and Tuberculosis, Multidrug-Resistant
| Article | Year |
|---|---|
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment.
Topics: Amoxicillin; Antitubercular Agents; Azithromycin; Cilastatin; Clarithromycin; Clavulanic Acid; HIV Infections; Humans; Imipenem; Isoxazoles; Macrolides; Meropenem; Mycobacterium tuberculosis; Oxazolidinones; Randomized Controlled Trials as Topic; Thienamycins; Thioridazine; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
Mycobacteria as pathogens of respiratory infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; BCG Vaccine; Clarithromycin; Humans; Lung Diseases; Mycobacterium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Mycobacterium tuberculosis; Protease Inhibitors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
3 trial(s) available for clarithromycin and Tuberculosis, Multidrug-Resistant
| Article | Year |
|---|---|
Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients.
Topics: Acetamides; Adult; Aged; Antitubercular Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Drug Interactions; Drug Monitoring; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Prospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis.
Topics: Acetamides; Adult; Antitubercular Agents; Area Under Curve; Clarithromycin; Confidence Intervals; Drug Monitoring; Female; Humans; Linezolid; Male; Metabolic Clearance Rate; Oxazolidinones; Prospective Studies; Saliva; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.
Topics: Antitubercular Agents; Clarithromycin; Cycloserine; Dapsone; Diarylquinolines; Erythromycin; Female; Humans; Isoxazoles; Male; Ofloxacin; Oxazolidinones; Quinolines; Tuberculosis, Multidrug-Resistant | 2012 |
11 other study(ies) available for clarithromycin and Tuberculosis, Multidrug-Resistant
| Article | Year |
|---|---|
Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Clarithromycin; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Recurrence; Sputum; Tuberculosis, Multidrug-Resistant | 2017 |
Clinical significance of QT-prolonging drug use in patients with MDR-TB or NTM disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Azithromycin; Child; Clarithromycin; Clofazimine; Diarylquinolines; Female; Fluoroquinolones; Follow-Up Studies; Humans; Lost to Follow-Up; Macrolides; Male; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nitroimidazoles; Nontuberculous Mycobacteria; Oxazoles; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Salvage therapy for multidrug-resistant tuberculosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Capreomycin; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Male; Moxifloxacin; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Salvage Therapy; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
Topics: Acetamides; Antitubercular Agents; Clarithromycin; Female; Humans; Linezolid; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2013 |
In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis.
Topics: Acetamides; Anti-Bacterial Agents; Biological Specimen Banks; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2014 |
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Female; Humans; Inappropriate Prescribing; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Diseases; Macrolides; Male; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tuberculosis, Multidrug-Resistant | 2016 |
[A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
Topics: Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
Topics: Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Ethionamide; Female; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rwanda; Tuberculosis, Multidrug-Resistant | 2008 |
Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 1995 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |